PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'CAS Key Laboratory of Quantitative Engineering Biology, Shenzhen Institute of Synthetic Biology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, People\'s Republic of China.\', \'School of Biomedical Sciences, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, People\'s Republic of China.\', \'State Key Laboratory of Emerging Infectious Diseases, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, People\'s Republic of China.\', \'Department of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, People\'s Republic of China.\', \'Department of Chemistry, Faculty of Science, The University of Hong Kong, Pokfulam, People\'s Republic of China.\', \'AIDS Institute, Li Ka Shing Faculty of Medicine, The University of Hong Kong, People\'s Republic of China.\', \'Department of Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, People\'s Republic of China.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1080/22221751.2021.1921621
?:hasPublicationType
?:journal
  • Emerging microbes & infections
is ?:pmid of
?:pmid
?:pmid
  • 33890550
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • A novel linker-immunodominant site (LIS) vaccine targeting the SARS-CoV-2 spike protein protects against severe COVID-19 in Syrian hamsters.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all